Chimeric antigen receptor T-cell (CAR-T) therapy has been prosperous in the treatment of
patients with various types of relapsed/refractory (R/R) B-cell malignancies including diffuse …

Traditional views of nutritional carcinogenesis depend on the identification of exogenous
carcinogens as major risk factors. As our understanding evolves, it is clear that the pattern of …

Mature T cell cancers are typically aggressive, treatment resistant and associated with poor
prognosis. Clinical application of immunotherapeutic approaches has been limited by a lack …

Among 1153 new adult cases of peripheral/T-cell lymphoma from 1990-2002 at 22 centers
in 13 countries, 136 cases (11.8%) of extranodal natural killer (NK)/T-cell lymphoma were …

Abstract The International Peripheral T-cell Lymphoma Project is a collaborative effort to
better understand peripheral T-cell lymphoma (PTCL). A total of 22 institutions submitted …

To complement the existing treatment guidelines for all tumour types, ESMO organizes
consensus conferences to focus on specific issues in each type of tumour. In this setting, a …

The molecular alterations underlying the pathogenesis of angioimmunoblastic T-cell
lymphoma (AITL) and peripheral T-cell lymphoma, unspecified (PTCL-u) are largely …

The present guidelines cover the systemic subtypes of primary nodal and primary extranodal
peripheral T-cell lymphomas (PTCLs). ESMO guidelines for primary cutaneous T-cell …

Peripheral T-cell lymphoma (PTCL) is often challenging to diagnose and classify. Gene
expression profiling was performed on 144 cases of PTCL and natural killer cell lymphoma …

To evaluate the prognostic significance of clinicobiologic and pathological features in
angioimmunoblastic T-cell lymphoma (AITL), 157 AITL patients were retrieved from the …